Biological functions of iduronic acid in chondroitin/dermatan sulfate

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2431-2446

  Thelin, Martin A ^a   Bartolini, Barbara ^a,b   Axelsson, Jakob ^a   Gustafsson, Renata ^a   Tykesson, Emil ^a   Pera, Edgar ^a   Oldberg, Åke ^a   MacCarana, Marco ^a   Malmstrom, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

cancer; dermatan sulfate epimerase; DSE; DSEL; iduronic acid; inflammation; proteoglycans

Indexed keywords

CHONDROITIN SULFATE; CYTOKINE; DERMATAN SULFATE; GROWTH FACTOR; IDURONIC ACID;

ADDUCTED THUMB CLUBFOOT SYNDROME; ANGIOGENESIS; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD CLOTTING; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CONNECTIVE TISSUE; EHLERS DANLOS SYNDROME; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STEM CELL; WOUND HEALING;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, NEOPLASM; CARBOHYDRATE EPIMERASES; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CHONDROITIN SULFATES; DERMATAN SULFATE; DNA-BINDING PROTEINS; EHLERS-DANLOS SYNDROME; EXTRACELLULAR MATRIX; FOOT DEFORMITIES, CONGENITAL; HAND DEFORMITIES, CONGENITAL; HUMANS; IDURONIC ACID; MOLECULAR CONFORMATION; NEOPLASM PROTEINS; STEM CELLS; SULFOTRANSFERASES; THUMB;

EID: 84877701739     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12214     Document Type: Review

References (146)

1. Malmstrom A, Bartolini B, Thelin MA, Pacheco B, &, Maccarana M, (2012) Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function. J Histochem Cytochem 60, 916-925.
2. Yamada S, Sugahara K, &, Ozbek S, (2011) Evolution of glycosaminoglycans: comparative biochemical study. Commun Integr Biol 4, 150-158.
3. Yamada S, &, Sugahara K, (2008) Potential therapeutic application of chondroitin sulfate/dermatan sulfate. Curr Drug Discov Technol 5, 289-301.
4. Malmstrom A, (1984) Biosynthesis of dermatan sulfate. II. Substrate specificity of the C-5 uronosyl epimerase. J Biol Chem 259, 161-165. (Pubitemid 14177641)
5. Ferro DR, Provasoli A, Ragazzi M, Casu B, Torri G, Bossennec V, Perly B, Sinay P, Petitou M, &, Choay J, (1990) Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Carbohydr Res 195, 157-167.
6. Cheng F, Heinegard D, Malmstrom A, Schmidtchen A, Yoshida K, &, Fransson LA, (1994) Patterns of uronosyl epimerization and 4-/6-O-sulphation in chondroitin/dermatan sulphate from decorin and biglycan of various bovine tissues. Glycobiology 4, 685-696. (Pubitemid 24327734)
7. Fransson LA, Coster L, Havasmark B, Malmstrom A, &, Sjoberg I, (1974) The copolymeric structure of pig skin dermatan sulphate. Isolation and characterization of L-idurono-sulphate-containing oligosaccharides from copolymeric chains. Biochem J 143, 379-389.
8. Fransson LA, Coster L, Malmstrom A, &, Sjoberg I, (1974) The copolymeric structure of pig skin dermatan suplhate. Characterization of D-glucuronic acid-containing oligosaccharides isolated after controlled degradation of oxydermatan sulphate. Biochem J 143, 369-378.
9. Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M, Westergren-Thorsson G, &, Malmstrom A, (2005) Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes. Glycobiology 15, 1277-1285. (Pubitemid 41724332)
10. Ambrosius M, Kleesiek K, &, Gotting C, (2009) Quantitative determination and comparison of the glycosaminoglycan delta-disaccharide composition in 22 different human cell lines. Cell Biol Int 33, 848-852.
11. Mizumoto S, &, Sugahara K, (2012) Glycosaminoglycan chain analysis and characterization (glycosylation/epimerization). Methods Mol Biol 836, 99-115.
12. Miller MJ, Costello CE, Malmstrom A, &, Zaia J, (2006) A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms. Glycobiology 16, 502-513. (Pubitemid 43779046)
13. Thelin MA, Svensson KJ, Shi X, Bagher M, Axelsson J, Isinger-Ekstrand A, van Kuppevelt TH, Johansson J, Nilbert M, Zaia J, et al,. (2012) Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res 72, 1943-1952.
14. Ly M, Leach FE III, Laremore TN, Toida T, Amster IJ, &, Linhardt RJ, (2011) The proteoglycan bikunin has a defined sequence. Nat Chem Biol 7, 827-833.
15. Goossens D, Van Gestel S, Claes S, De Rijk P, Souery D, Massat I, Van den BD, Backhovens H, Mendlewicz J, Van Broeckhoven C, et al,. (2003) A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder. Mol Psychiatry 8, 83-89. (Pubitemid 36188576)
16. Pacheco B, Malmstrom A, &, Maccarana M, (2009) Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate. J Biol Chem 284, 9788-9795.
17. Pinhal MA, Smith B, Olson S, Aikawa J, Kimata K, &, Esko JD, (2001) Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo. Proc Natl Acad Sci USA 98, 12984-12989. (Pubitemid 33054083)
18. Presto J, Thuveson M, Carlsson P, Busse M, Wilen M, Eriksson I, Kusche-Gullberg M, &, Kjellen L, (2008) Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc Natl Acad Sci USA 105, 4751-4756. (Pubitemid 351753818)
19. Shaya D, Tocilj A, Li Y, Myette J, Venkataraman G, Sasisekharan R, &, Cygler M, (2006) Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem 281, 15525-15535. (Pubitemid 43855145)
20. Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta K, Takamori S, et al,. (2000) Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J Immunol 164, 2565-2574. (Pubitemid 30115487)
21. Maccarana M, Olander B, Malmstrom J, Tiedemann K, Aebersold R, Lindahl U, Li JP, &, Malmstrom A, (2006) Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem 281, 11560-11568. (Pubitemid 43855412)
22. Bartolini B, Thelin MA, Rauch U, Feinstein R, Oldberg A, Malmstrom A, &, Maccarana M, (2012) Mouse development is not obviously affected by the absence of dermatan sulfate epimerase 2 in spite of a modified brain dermatan sulfate composition. Glycobiology 22, 1007-1016.
23. Malmstrom A, &, Fransson LA, (1975) Biosynthesis of dermatan sulfate. I. Formation of L-iduronic acid residues. J Biol Chem 250, 3419-3425.
24. Pacheco B, Maccarana M, &, Malmstrom A, (2009) Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate. Glycobiology 19, 1197-1203.
25. Miyake N, Kosho T, Mizumoto S, Furuichi T, Hatamochi A, Nagashima Y, Arai E, Takahashi K, Kawamura R, Wakui K, et al,. (2010) Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat 31, 966-974.
26. Tiedemann K, Malmstrom A, &, Westergren-Thorsson G, (1997) Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. Matrix Biol 15, 469-478. (Pubitemid 27135734)
27. Lin F, Ren XD, Pan Z, Macri L, Zong WX, Tonnesen MG, Rafailovich M, Bar-Sagi D, &, Clark RA, (2011) Fibronectin growth factor-binding domains are required for fibroblast survival. J Invest Dermatol 131, 84-98.
28. Maccarana M, Kalamajski S, Kongsgaard M, Magnusson SP, Oldberg A, &, Malmstrom A, (2009) Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol Cell Biol 29, 5517-5528.
29. Seidler DG, Breuer E, Grande-Allen KJ, Hascall VC, &, Kresse H, (2002) Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J Biol Chem 277, 42409-42416. (Pubitemid 35264601)
30. Herzog C, Lippmann I, Grobe K, Zamfir AD, Echtermeyer F, &, Seidler DG, (2011) The amino acid tryptophan prevents the biosynthesis of dermatan sulfate. Mol BioSyst 7, 2872-2881.
31. Akatsu C, Mizumoto S, Kaneiwa T, Maccarana M, Malmstrom A, Yamada S, &, Sugahara K, (2011) Dermatan sulfate epimerase 2 is the predominant isozyme in the formation of the chondroitin sulfate/dermatan sulfate hybrid structure in postnatal developing mouse brain. Glycobiology 21, 565-574.
32. Shimizu K, Okamoto N, Miyake N, Taira K, Sato Y, Matsuda K, Akimaru N, Ohashi H, Wakui K, Fukushima Y, et al,. (2011) Delineation of dermatan 4-O-sulfotransferase 1 deficient Ehlers-Danlos syndrome: observation of two additional patients and comprehensive review of 20 reported patients. Am J Med Genet A 155A, 1949-1958.
33. Dundar M, Muller T, Zhang Q, Pan J, Steinmann B, Vodopiutz J, Gruber R, Sonoda T, Krabichler B, Utermann G, et al,. (2009) Loss of dermatan-4- sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. Am J Hum Genet 85, 873-882.
34. Voermans NC, Kempers M, Lammens M, van Alfen N, Janssen MC, Bonnemann C, van Engelen BG, &, Hamel BC, (2012) Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation. Am J Med Genet A 158A, 850-855.
35. Nairn AV, Kinoshita-Toyoda A, Toyoda H, Xie J, Harris K, Dalton S, Kulik M, Pierce JM, Toida T, Moremen KW, et al,. (2007) Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J Proteome Res 6, 4374-4387. (Pubitemid 350158513)
36. Purushothaman A, Sugahara K, &, Faissner A, (2012) Chondroitin sulfate 'wobble motifs' modulate maintenance and differentiation of neural stem cells and their progeny. J Biol Chem 287, 2935-2942.
37. Bian S, Akyuz N, Bernreuther C, Loers G, Laczynska E, Jakovcevski I, &, Schachner M, (2011) Dermatan sulfotransferase Chst14/D4st1, but not chondroitin sulfotransferase Chst11/C4st1, regulates proliferation and neurogenesis of neural progenitor cells. J Cell Sci 124, 4051-4063.
38. Yamauchi S, Kurosu A, Hitosugi M, Nagai T, Oohira A, &, Tokudome S, (2011) Differential gene expression of multiple chondroitin sulfate modification enzymes among neural stem cells, neurons and astrocytes. Neurosci Lett 493, 107-111.
39. Maeda N, Fukazawa N, &, Ishii M, (2010) Chondroitin sulfate proteoglycans in neural development and plasticity. Front Biosci 15, 626-644.
40. Crespo D, Asher RA, Lin R, Rhodes KE, &, Fawcett JW, (2007) How does chondroitinase promote functional recovery in the damaged CNS? Exp Neurol 206, 159-171. (Pubitemid 47094767)
41. Mitsunaga C, Mikami T, Mizumoto S, Fukuda J, &, Sugahara K, (2006) Chondroitin sulfate/dermatan sulfate hybrid chains in the development of cerebellum. Spatiotemporal regulation of the expression of critical disulfated disaccharides by specific sulfotransferases. J Biol Chem 281, 18942-18952. (Pubitemid 44035397)
42. Sugahara K, &, Mikami T, (2007) Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol 17, 536-545. (Pubitemid 350019013)
43. Malavaki C, Mizumoto S, Karamanos N, &, Sugahara K, (2008) Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease. Connect Tissue Res 49, 133-139.
44. Trowbridge JM, &, Gallo RL, (2002) Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12, 117R-125R.
45. Penc SF, Pomahac B, Eriksson E, Detmar M, &, Gallo RL, (1999) Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1. J Clin Invest 103, 1329-1335. (Pubitemid 29218303)
46. Penc SF, Pomahac B, Winkler T, Dorschner RA, Eriksson E, Herndon M, &, Gallo RL, (1998) Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 273, 28116-28121. (Pubitemid 28496107)
47. Plichta JK, &, Radek KA, (2012) Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds. J Burn Care Res 33, 299-310.
48. Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, &, Miyasaka M, (2000) Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 275, 35448-35456.
49. Kozlowski EO, Pavao MS, &, Borsig L, (2011) Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. J Thromb Haemost 9, 1807-1815.
50. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, &, Wells TN, (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38, 12959-12968.
51. Petricevich VL, &, Michelacci YM, (1990) Proteoglycans synthesized in vitro by nude and normal mouse peritoneal macrophages. Biochim Biophys Acta 1053, 135-143. (Pubitemid 20220649)
52. Rho JH, Zhang W, Murali M, Roehrl MH, &, Wang JY, (2011) Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens. Am J Pathol 178, 2177-2190.
53. Wang JY, Lee J, Yan M, Rho JH, &, Roehrl MH, (2011) Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity. Am J Pathol 178, 2168-2176.
54. Camejo G, Hurt-Camejo E, Wiklund O, &, Bondjers G, (1998) Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 139, 205-222. (Pubitemid 28361804)
55. Iverius PH, (1972) The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem 247, 2607-2613.
56. Theocharis AD, Theocharis DA, De Luca G, Hjerpe A, &, Karamanos NK, (2002) Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84, 667-674. (Pubitemid 35282540)
57. Soto Y, Acosta E, Delgado L, Perez A, Falcon V, Becquer MA, Fraga A, Brito V, Alvarez I, Grinan T, et al,. (2012) Antiatherosclerotic effect of an antibody that binds to extracellular matrix glycosaminoglycans. Arterioscler Thromb Vasc Biol 32, 595-604.
58. Brito V, Mellal K, Portelance SG, Perez A, Soto Y, Deblois D, Ong H, Marleau S, &, Vazquez AM, (2012) Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 32, 2847-2853.
59. Blinder MA, Andersson TR, Abildgaard U, &, Tollefsen DM, (1989) Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate. J Biol Chem 264, 5128-5133. (Pubitemid 19092926)
60. Maimone MM, &, Tollefsen DM, (1990) Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem 265, 18263-18271.
61. Halldorsdottir AM, Zhang L, &, Tollefsen DM, (2006) N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate. Glycobiology 16, 693-701. (Pubitemid 44288235)
62. Tollefsen DM, (2010) Vascular dermatan sulfate and heparin cofactor II. Prog Mol Biol Transl Sci 93, 351-372.
63. He L, Giri TK, Vicente CP, &, Tollefsen DM, (2008) Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood 111, 4118-4125.
64. Fernandez JA, Petaja J, &, Griffin JH, (1999) Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Thromb Haemost 82, 1462-1468. (Pubitemid 29527640)
65. Brown EL, Wooten RM, Johnson BJ, Iozzo RV, Smith A, Dolan MC, Guo BP, Weis JJ, &, Hook M, (2001) Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 107, 845-852. (Pubitemid 32274037)
66. Schmidtchen A, Frick IM, &, Bjorck L, (2001) Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 39, 708-713. (Pubitemid 32162156)
67. Noguchi M, Kobayashi K, Suetsugu N, Tomiyasu K, Suekane S, Yamada A, Itoh K, &, Noda S, (2003) Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination. Prostate 57, 80-92. (Pubitemid 37070152)
68. Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, et al,. (2011) Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen-A24 with recurrent or progressive glioblastoma multiforme. J Clin Oncol 29, 337-344.
69. Mizukoshi E, Fushimi K, Arai K, Yamashita T, Honda M, &, Kaneko S, (2012) Expression of chondroitin-glucuronate C5-epimerase and cellular immune responses in patients with hepatocellular carcinoma. Liver Int 32, 1516-1526.
70. Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS, &, Theocharis DA, (2003) Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 35, 376-390. (Pubitemid 36084460)
71. Basappa Murugan S, Sugahara KN, Lee CM, ten Dam GB, van Kuppevelt TH, Miyasaka M, Yamada S, &, Sugahara K, (2009) Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells. Glycobiology 19, 735-742.
72. Li F, Ten Dam GB, Murugan S, Yamada S, Hashiguchi T, Mizumoto S, Oguri K, Okayama M, van Kuppevelt TH, &, Sugahara K, (2008) Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells. J Biol Chem 283, 34294-34304.
73. Mizumoto S, Takahashi J, &, Sugahara K, (2012) Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells. J Biol Chem 287, 18985-18994.
74. Deakin JA, Blaum BS, Gallagher JT, Uhrin D, &, Lyon M, (2009) The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns. J Biol Chem 284, 6311-6321.
75. Nikitovic D, Zafiropoulos A, Tzanakakis GN, Karamanos NK, &, Tsatsakis AM, (2005) Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 25, 2851-2856. (Pubitemid 41044672)
76. Denholm EM, Lin YQ, &, Silver PJ, (2001) Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion. Eur J Pharmacol 416, 213-221. (Pubitemid 32274248)
77. Westergren-Thorsson G, Persson S, Isaksson A, Onnervik PO, Malmstrom A, &, Fransson LA, (1993) L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 206, 93-99. (Pubitemid 23194683)
78. Heinegard D, (2009) Proteoglycans and more-from molecules to biology. Int J Exp Pathol 90, 575-586.
79. Ricciardelli C, Sakko AJ, Ween MP, Russell DL, &, Horsfall DJ, (2009) The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 28, 233-245.
80. Wu YJ, La Pierre DP, Wu J, Yee AJ, &, Yang BB, (2005) The interaction of versican with its binding partners. Cell Res 15, 483-494. (Pubitemid 41653919)
81. Wight TN, (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14, 617-623. (Pubitemid 35247746)
82. Yamaguchi Y, Mann DM, &, Ruoslahti E, (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346, 281-284.
83. Coster L, Fransson LA, Sheehan J, Nieduszynski IA, &, Phelps CF, (1981) Self-association of dermatan sulphate proteoglycans from bovine sclera. Biochem J 197, 483-490. (Pubitemid 11013979)
84. Neill T, Schaefer L, &, Iozzo RV, (2012) Decorin: a guardian from the matrix. Am J Pathol 181, 380-387.
85. Quentin E, Gladen A, Roden L, &, Kresse H, (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA 87, 1342-1346.
86. Fransson LA, Coster L, Malmstrom A, &, Sheehan JK, (1982) Self-association of scleral proteodermatan sulfate. Evidence for interaction via the dermatan sulfate side chains. J Biol Chem 257, 6333-6338.
87. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, &, Ruoslahti E, (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302, 527-534. (Pubitemid 24280108)
88. Moreno M, Munoz R, Aroca F, Labarca M, Brandan E, &, Larrain J, (2005) Biglycan is a new extracellular component of the chordin-BMP4 signaling pathway. EMBO J 24, 1397-1405. (Pubitemid 40593060)
89. Schonherr E, Hausser H, Beavan L, &, Kresse H, (1995) Decorin-type I collagen interaction. Presence of separate core protein-binding domains. J Biol Chem 270, 8877-8883.
90. Wang B, Li GX, Zhang SG, Wang Q, Wen YG, Tang HM, Zhou CZ, Xing AY, Fan JW, Yan DW, et al,. (2011) Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp Biol Med (Maywood) 236, 1247-1253.
91. Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Matsuda K, et al,. (2012) Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer 106, 1214-1223.
92. Westergren-Thorsson G, Hernnas J, Sarnstrand B, Oldberg A, Heinegard D, &, Malmstrom A, (1993) Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 92, 632-637. (Pubitemid 23262379)
93. Hou S, Maccarana M, Min TH, Strate I, &, Pera EM, (2007) The secreted serine protease xHtrA1 stimulates long-range FGF signaling in the early Xenopus embryo. Dev Cell 13, 226-241. (Pubitemid 47163609)
94. Kappler J, Junghans U, Koops A, Stichel CC, Hausser HJ, Kresse H, &, Muller HW, (1997) Chondroitin/dermatan sulphate promotes the survival of neurons from rat embryonic neocortex. Eur J Neurosci 9, 306-318. (Pubitemid 27091110)
95. Young MF, Bi Y, Ameye L, &, Chen XD, (2002) Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J 19, 257-262. (Pubitemid 37174553)
96. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, et al,. (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20, 78-82. (Pubitemid 28410350)
97. Johnson HJ, Rosenberg L, Choi HU, Garza S, Hook M, &, Neame PJ, (1997) Characterization of epiphycan, a small proteoglycan with a leucine-rich repeat core protein. J Biol Chem 272, 18709-18717. (Pubitemid 27318215)
98. Johnson J, Shinomura T, Eberspaecher H, Pinero G, Decrombrugghe B, &, Hook M, (1999) Expression and localization of PG-Lb/epiphycan during mouse development. Dev Dyn 216, 499-510.
99. McCormick D, van der Rest M, Goodship J, Lozano G, Ninomiya Y, &, Olsen BR, (1987) Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. Proc Natl Acad Sci USA 84, 4044-4048. (Pubitemid 17090871)
100. Koch M, Bohrmann B, Matthison M, Hagios C, Trueb B, &, Chiquet M, (1995) Large and small splice variants of collagen XII: differential expression and ligand binding. J Cell Biol 130, 1005-1014.
101. Watt SL, Lunstrum GP, McDonough AM, Keene DR, Burgeson RE, &, Morris NP, (1992) Characterization of collagen types XII and XIV from fetal bovine cartilage. J Biol Chem 267, 20093-20099.
102. Agarwal P, Zwolanek D, Keene DR, Schulz JN, Blumbach K, Heinegard D, Zaucke F, Paulsson M, Krieg T, Koch M, et al,. (2012) Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure. J Biol Chem 287, 22549-22559.
103. Bilandzic M, &, Stenvers KL, (2012) Reprint of: betaglycan: a multifunctional accessory. Mol Cell Endocrinol 359, 13-22.
104. Andres JL, Ronnstrand L, Cheifetz S, &, Massague J, (1991) Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan. J Biol Chem 266, 23282-23287. (Pubitemid 21908791)
105. Gatza CE, Oh SY, &, Blobe GC, (2010) Roles for the type III TGF-beta receptor in human cancer. Cell Signal 22, 1163-1174.
106. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, &, Vale W, (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404, 411-414. (Pubitemid 30164345)
107. Teng YH, Aquino RS, &, Park PW, (2012) Molecular functions of syndecan-1 in disease. Matrix Biol 31, 3-16.
108. Lee PH, Trowbridge JM, Taylor KR, Morhenn VB, &, Gallo RL, (2004) Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J Biol Chem 279, 48640-48646. (Pubitemid 39625739)
109. Deepa SS, Yamada S, Zako M, Goldberger O, &, Sugahara K, (2004) Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J Biol Chem 279, 37368-37376. (Pubitemid 39195445)
110. Cluff AH, Bystrom B, Klimaviciute A, Dahlqvist C, Cebers G, Malmstrom A, &, Ekman-Ordeberg G, (2006) Prolonged labour associated with lower expression of syndecan 3 and connexin 43 in human uterine tissue. Reprod Biol Endocrinol 4, 24.
111. Hjelm CA, Malmstrom A, Tingaker B, David G, &, Ekman-Ordeberg G, (2005) Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localization. Acta Obstet Gynecol Scand 84, 217-224. (Pubitemid 40333100)
112. Nakanishi T, Kadomatsu K, Okamoto T, Ichihara-Tanaka K, Kojima T, Saito H, Tomoda Y, &, Muramatsu T, (1997) Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem 121, 197-205. (Pubitemid 27096193)
113. Roskams T, De Vos R, David G, Van Damme B, &, Desmet V, (1998) Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol 185, 290-297. (Pubitemid 28320051)
114. Munoz R, Moreno M, Oliva C, Orbenes C, &, Larrain J, (2006) Syndecan-4 regulates non-canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos. Nat Cell Biol 8, 492-500.
115. Matthews HK, Marchant L, Carmona-Fontaine C, Kuriyama S, Larrain J, Holt MR, Parsons M, &, Mayor R, (2008) Directional migration of neural crest cells in vivo is regulated by syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. Development 135, 1771-1780.
116. Kuriyama S, &, Mayor R, (2009) A role for syndecan-4 in neural induction involving ERK- and PKC-dependent pathways. Development 136, 575-584.
117. Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, &, Goetinck P, (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 107, R9-R14. (Pubitemid 32096841)
118. Beauvais DM, &, Rapraeger AC, (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2, 3.
119. Zoller M, (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11, 254-267.
120. Price MA, Colvin Wanshura LE, Yang J, Carlson J, Xiang B, Li G, Ferrone S, Dudek AZ, Turley EA, &, McCarthy JB, (2011) CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma. Pigment Cell Melanoma Res 24, 1148-1157.
121. Stallcup WB, (2002) The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31, 423-435. (Pubitemid 37378256)
122. Franco CR, Trindade ES, Rocha HA, da Silveira RB, Paludo KS, Chammas R, Veiga SS, Nader HB, &, Dietrich CP, (2009) Glycosaminoglycan chains from alpha5beta1 integrin are involved in fibronectin-dependent cell migration. Biochem Cell Biol 87, 677-686.
123. Zachary IC, (2011) How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns. Biochem Soc Trans 39, 1583-1591.
124. Varga I, Hutoczki G, Szemcsak CD, Zahuczky G, Toth J, Adamecz Z, Kenyeres A, Bognar L, Hanzely Z, &, Klekner A, (2012) Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma. Pathol Oncol Res 18, 413-420.
125. Ida M, Shuo T, Hirano K, Tokita Y, Nakanishi K, Matsui F, Aono S, Fujita H, Fujiwara Y, Kaji T, et al,. (2006) Identification and functions of chondroitin sulfate in the milieu of neural stem cells. J Biol Chem 281, 5982-5991. (Pubitemid 43847699)
126. Muller S, Kunkel P, Lamszus K, Ulbricht U, Lorente GA, Nelson AM, von Schack D, Chin DJ, Lohr SC, Westphal M, et al,. (2003) A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene 22, 6661-6668. (Pubitemid 37372206)
127. Adamsky K, Schilling J, Garwood J, Faissner A, &, Peles E, (2001) Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C. Oncogene 20, 609-618. (Pubitemid 32156185)
128. Feng ZJ, Gao SB, Wu Y, Xu XF, Hua X, &, Jin GH, (2010) Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP beta/zeta signaling by menin. Oncogene 29, 5416-5426.
129. Hu B, Kong LL, Matthews RT, &, Viapiano MS, (2008) The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 283, 24848-24859.
130. Viapiano MS, Hockfield S, &, Matthews RT, (2008) BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. J Neurooncol 88, 261-272.
131. Frischknecht R, &, Seidenbecher CI, (2012) Brevican: a key proteoglycan in the perisynaptic extracellular matrix of the brain. Int J Biochem Cell Biol 44, 1051-1054.
132. Thinakaran G, Slunt HH, &, Sisodia SS, (1995) Novel regulation of chondroitin sulfate glycosaminoglycan modification of amyloid precursor protein and its homologue, APLP2. J Biol Chem 270, 16522-16525.
133. Iozzo RV, Zoeller JJ, &, Nystrom A, (2009) Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol Cells 27, 503-513.
134. Aviezer D, Hecht D, Safran M, Eisinger M, David G, &, Yayon A, (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005-1013.
135. Iozzo RV, &, Sanderson RD, (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15, 1013-1031.
136. Ghiselli G, &, Iozzo RV, (2000) Overexpression of bamacan/SMC3 causes transformation. J Biol Chem 275, 20235-20238. (Pubitemid 30457592)
137. Lauer M, Scruggs B, Chen S, Wassenhove-McCarthy D, &, McCarthy KJ, (2007) Leprecan distribution in the developing and adult kidney. Kidney Int 72, 82-91. (Pubitemid 47014449)
138. Harris A, Harris H, &, Hollingsworth MA, (2007) Complete suppression of tumor formation by high levels of basement membrane collagen. Mol Cancer Res 5, 1241-1245.
139. Chang MY, Chan CK, Braun KR, Green PS, O'Brien KD, Chait A, Day AJ, &, Wight TN, (2012) Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J Biol Chem 287, 14122-14135.
140. Tanaka K, Arao T, Tamura D, Aomatsu K, Furuta K, Matsumoto K, Kaneda H, Kudo K, Fujita Y, Kimura H, et al,. (2012) SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer. PLoS ONE 7, e27922.
141. Bechard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, Pestel J, Dessaint JP, Tonnel AB, &, Lassalle P, (2001) Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 167, 3099-3106. (Pubitemid 32852547)
142. Scherpereel A, Gentina T, Grigoriu B, Senechal S, Janin A, Tsicopoulos A, Plenat F, Bechard D, Tonnel AB, &, Lassalle P, (2003) Overexpression of endocan induces tumor formation. Cancer Res 63, 6084-6089. (Pubitemid 37187514)
143. Roll S, Seul J, Paulsson M, &, Hartmann U, (2006) Testican-1 is dispensable for mouse development. Matrix Biol 25, 373-381. (Pubitemid 44175831)
144. Nakada M, Miyamori H, Yamashita J, &, Sato H, (2003) Testican 2
145. Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J, &, Sato H, (2001) Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 61, 8896-8902. (Pubitemid 34013906)
146. Zhuo L, Salustri A, &, Kimata K, (2002) A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role. Glycoconj J 19, 241-247. (Pubitemid 37174551)